This post analyses the IP waiver proposal for Covid-19 vaccines and the USPTO’s stance on AI inventorship, focusing on their legal implications. It also covers recent international patent settlements and policy updates with an objective, legal-academic perspective.
Read more about IP waiver on Covid-19 vaccine, AI lacks ‘legal personality’ says USPTO to Court and more